Jan Van den Bossche is a member of the Board of Directors at Immunic Therapeutics. Prior to this, they were with Aelin Therapeutics, OCTIMET Oncology NV, and Fund+. Jan has also worked with DSM and Petercam.
Jan Van den Bossche has a Master's degree in Applied Economics from Katholieke Universiteit Leuven and also studied at Hemaco.
Current role